Cells of the Nervous System

  • Carl Rosenblad
  • Cecilia Lundberg
Part of the Methods in Molecular Biology™ book series (MIMB, volume 229)


Direct in vivo gene transfer to the central nervous system (CNS) using recombinant lentiviral vectors (rLV) has emerged as a powerful technique to overexpress various genes of interest in different neuronal populations. This interest is exemplified by the increasing number of studies using rLV vectors to evaluate therapeutic proteins to correct disorders of the nervous system (1, 2, 3) or to explore a protein’s involvement in normal function or pathological processes (4). Compared to conventional trangenic techniques for overexpression, rLVs have several attractive features. For example, the level of transgene expression in cells transduced with a rLV is typically higher than obtained with knock-in techniques and is present already at 3–4 d after injection in vivo (5). Second, the expression may be directed to specific regions or cell populations depending on the anatomical location of the rLV injections as well as the design of the vector system. This may be advantageous for the study design since it allows unilateral overexpression, thereby creating an internal control in functional and morphological studies. Finally, it is considerably less time consuming than creating transgenic mouse lines.


Green Fluorescent Protein Human Immunodeficiency Virus Type Feline Immunodeficiency Virus Incubation Buffer Equine Infectious Anemia Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    de Almeida, L. P., Zala, D., Aebischer, P., and Deglon, N. (2001) Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington’s disease. Neurobiol. Dis. 8, 433–446.PubMedCrossRefGoogle Scholar
  2. 2.
    Kordower, J. H., Emborg, M. E., Bloch, J., et al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290, 767–773.PubMedCrossRefGoogle Scholar
  3. 3.
    Rosenblad, C., Gronborg, M., Hansen, C., et al. (2000) In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin. Mol. Cell Neurosci. 15, 199–214.PubMedCrossRefGoogle Scholar
  4. 4.
    Lobianco, C., Ridet, J. L., Zurn, A., Deglon, N., and Aebischer, P. (2001) Dopaminergic cell loss induced by lentiviral mediated overexpression of wild type or mutant human alpha synuclein in the substantia nigra of rats. Society for Neuroscience Abstract 324, 10.Google Scholar
  5. 5.
    Georgievska, B., Kirik, D., Rosenblad, C., Lundberg, C., and Bjorklund, A. (2002) Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. Neuroreport 13, 1–8.CrossRefGoogle Scholar
  6. 6.
    Blomer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., and Gage, F. H. (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641–6649.PubMedGoogle Scholar
  7. 7.
    Naldini, L., Blomer, U., Gage, F. H., Trono, D., Verma, I. M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl. Acad. Sci. USA 93, 11,382–11,388.PubMedCrossRefGoogle Scholar
  8. 8.
    Mitrophanous, K., Yoon, S., Rohll, J., et al. (1999) Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808–1818.PubMedCrossRefGoogle Scholar
  9. 9.
    Alisky, J. M., Huges, S. M., Sauter, S. L., et al. (2000) Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11, 2669–2673.PubMedCrossRefGoogle Scholar
  10. 10.
    Zufferey, R., Dull, T., Mandel, R. J., et al. (19??) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873–9880.Google Scholar
  11. 11.
    Kirik, D., Rosenblad, C., Bjorklund, A., and Mandel, R. J. (2000) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson’s model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci. 20, 4686–4700.PubMedGoogle Scholar
  12. 12.
    Kostic, C., Chiodini, F., Hornfeld, D., et al. (2001) Activity analysis of viral and housekeeping gene promoters using self-inactivating lentivirus vector delivery into the mouse retina. Society for Neuroscience Abstract 720, 8.Google Scholar
  13. 13.
    Ericson, C. A., Jansson, M., Björk, E., Wictorin, K., and Lundberg, C. (2001) In vivo studies of different promoters using a lentiviral vector system. Society for Neuroscience Abstract 257, 17.Google Scholar
  14. 14.
    Miyoshi, H., Takahashi, M., Gage, F. H., and Verma, I. M. (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94, 10,319–10,323.PubMedCrossRefGoogle Scholar
  15. 15.
    Mazarakis, N. D., Azzouz, M., Rohll, J. B., et al. (2001) Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109–2121.PubMedCrossRefGoogle Scholar
  16. 16.
    Kordower, J. H., Bloch, J., Ma, S. Y., et al. (1999) Lentiviral gene transfer to the nonhuman primate brain. Exp. Neurol. 160, 1–16.PubMedCrossRefGoogle Scholar
  17. 17.
    Dull, T., Zufferey, R., Kelly, M., et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463–8471.PubMedGoogle Scholar
  18. 18.
    Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H., and Verma, I. M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150–8157.PubMedGoogle Scholar
  19. 19.
    Nikkhah, G., Olsson, M., Eberhard, J., Bentlage, C., Cunningham, M. G., and Bjorklund, A. (1994) A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63, 57–72.PubMedCrossRefGoogle Scholar
  20. 20.
    Jonkers, B. W., Sterk, J. C., and Wonterlood, F. G. (1984) Transcardial perfusion fixation of the CNS by means of a compressed-air-driven device. J. Neurosci. Meth. 12, 141–149.CrossRefGoogle Scholar
  21. 21.
    Paxinos, G. and Watson, C. (1997) The rat brain in stereotaxic coordinates, 3rd ed., Academic Press, San Diego, CA.Google Scholar

Copyright information

© Humana Press Inc. 2003

Authors and Affiliations

  • Carl Rosenblad
    • 1
  • Cecilia Lundberg
    • 2
  1. 1.NsGene A/SBallerupDenmark
  2. 2.Department of Physiological SciencesLund UniversityLundSweden

Personalised recommendations